Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Therapy in Patients With Atrial Fibrillation (US)

NCT05055921 is registered in ClinicalTrials.gov with Cardialen, Inc. as lead sponsor.

NCT NCT05055921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Therapy in Patients With Atrial Fibrillation (US)
Lead sponsor
Cardialen, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2022
Completion date
October 1, 2022
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, paroxysmal atrial fibrillation, persistent atrial fibrillation